Pigment epithelium-derived factor (PEDF) is a multifunctional secreted glycoprotein that displays broad antitumor activity based on dual targeting of the tumor microenvironment (anti-angiogenic action) and the tumor cells (direct anti-tumor action). Here, we show that PEDF expression is high in melanocytes, but it is lost during malignant progression of human melanoma. Using a highthroughput analysis of the data from microarray studies of molecular profiling of human melanoma, we found that PEDF expression is lost in highly invasive melanomas. In paired cell lines established from the same lesion but representing the high and low extremes of malignant potential, abundant PEDF expression was restricted to the poorly aggressive counterparts. We used RNA interference to directly address the functional consequences of PEDF silencing. PEDF knockdown in poorly aggressive melanoma cell lines augmented migration, invasion and vasculogenic mimicry, which translated into an increased in vivo metastatic potential. PEDF interference also significantly enhanced the migratory and invasive capability of normal melanocytes and moderately increased their proliferative potential. Our results show that loss of PEDF enables melanoma cells to acquire an invasive phenotype and, therefore, modulation of this multifunctional factor could be critical for the malignant progression of human melanoma.
Introduction
Pigment epithelium-derived factor (PEDF) is a 50 kDa secreted glycoprotein from the serin protease inhibitor (SERPIN) superfamily (Becerra, 1997) . It was initially described in retinal pigment epithelial cells (Steele et al., 1993) , but later found to be expressed in several cell types (Bilak et al., 1999 (Bilak et al., , 2002 Sawant et al., 2004; Uehara et al., 2004; Quan et al., 2005) .
Several biological activities have been ascribed to PEDF, including neurotrophic and neuroprotective properties, inhibition of proliferation and induction of differentiation and apoptosis. How PEDF controls this variety of biological responses remains largely unknown; it presumably binds to cell surface receptors to trigger various signaling cascades. Specific biological response could be determined through the expression of different PEDF receptors. There is evidence to support the existence of at least two different PEDF receptors, each, respectively, specific to neuronal (Alberdi et al., 1999; Bilak et al., 1999; Aymerich et al., 2001) or endothelial cells (Yamagishi et al., 2004; Filleur et al., 2005) . A PEDF receptor recently cloned and characterized from retina shows phospholipase A2 activity on PEDF binding (Notari et al., 2006) . The signaling pathways activated by PEDF regulate a number of key transcription factors including NF-kB (Yabe et al., 2001) , NFAT (Zaichuk et al., 2004) and PPARg (Ho et al., 2007) .
Although signaling cascades elicited by PEDF are poorly defined, its functional roles are well characterized in a number of tissues, under physiological and pathological conditions. The variety of cell types and functions targeted by PEDF indicates it is a critical mediator in multiple processes; its lack or deregulation likely contributes to a number of pathologies of the eye and central nervous system (Tombran-Tink and Barnstable, 2003) . More recently, its potential role in cancer has been investigated in several tumor types (Ek et al., 2006a; Fernandez-Garcia et al., 2007) .
PEDF is a potent endogenous inhibitor of angiogenesis, which determines proper vascularization in the adult retina and other eye compartments (Dawson et al., 1999; Bouck, 2002) . These anti-angiogenic properties prompted the study of PEDF anti-tumor activity. We (Garcia et al., 2004; Fernandez-Garcia et al., 2007) and others Ek et al., 2006b ) uncovered a complex mechanism underlying the anti-tumor effects of PEDF, which includes indirect anti-tumor action through inhibition of angiogenesis, direct inhibition of tumor cell migration, induction of apoptosis and differentiation in certain tumor cell types.
PEDF expression changes in the course of progression of different tumor types. A number of studies show inverse correlation between PEDF levels, grade and metastatic potential of prostate adenocarcinoma (Halin et al., 2004) , pancreatic adenocarcinoma (Uehara et al., 2004) , glioblastoma (Guan et al., 2003) , hepatocellular carcinoma (Matsumoto et al., 2004) and Wilm's tumors .
Here, we analyze the expression of PEDF in human melanocytes and its regulation during their malignant conversion to melanoma. Defining melanoma progression is a difficult endeavor. It has evolved from the unidirectional transition models based on pathological criteria defining the radial growth phase (RGP), vertical growth phase (VGP) and metastatic phase of melanoma (Miller and Mihm, 2006) to the recently proposed reversible transition models based on the concept of molecular plasticity and reprograming (Hendrix et al., 2007) . Molecular profiling studies strongly support this later model in which reversible changes between proliferative and invasive states, defined by molecular signatures, are at the core of melanoma progression (Hoek et al., , 2008 . In this model, invasion from the growing primary tumor requires a transition from a proliferative to an invasive phenotype, which includes a number of changes enabling intravasation, survival in the circulation and extravasation at a distant site. In turn, reverse reprograming from invasive to proliferative phenotype drives tumorigenesis at a distant site.
We have described earlier the anti-tumor and antimetastatic effects achieved by retroviral transduction of PEDF in the aggressive human melanomas A375 and UCD-Mel-N (Garcia et al., 2004) . Here, we use a variety of approaches to analyze the changes in PEDF expression and the functional consequences of PEDF downregulation during malignant progression of human melanoma.
Results
PEDF is produced at high levels by skin melanocytes Using primary cell cultures, we found that melanocytes and fibroblasts are the two cell types that express and secrete higher levels of PEDF in the skin. We detected similar high levels of PEDF by western blot and ELISA in conditioned medium (CM) from melanocytes and skin fibroblasts but not from keratinocytes and microvascular endothelial cells (Figures 1a and b) . These results were consistent at mRNA level measured by quantitative RT-PCR, which showed that melanocytes expressed 476-and 126-fold more PEDF mRNA than endothelial cells or keratinocytes, respectively ( Figure 1c ). Retinoblastoma cell line Y79 (Seigel et al., 1994) , the hepatocarcinoma cell line HepG2 and primary hepatocytes (Sawant et al., 2004) were used as positive controls, showing that melanocytes expressed comparatively high levels of PEDF.
PEDF expression is lost in highly invasive melanomas To determine whether PEDF expression was modulated during melanoma genesis and progression, we measured PEDF expression in a small series of human melanoma cell lines representative of the RGP, VGP and metastatic phase of human melanoma. Western blot of CM showed that some RGP as well as VGP cell lines continue to express PEDF at levels similar to the primary cultures of melanocytes; however, nearly all metastatic cell lines tested lacked PEDF expression (Figure 2a ). This was further confirmed by ELISA ( Figure 2b ) and correlated with levels of intracellular PEDF protein ( Figure 2c ) and PEDF mRNA levels measured by quantitative RT-PCR (Figure 2d) . Mean PEDF mRNA level determined in primary melanocytes from six different donors was 24-fold higher than the mean of our collection of 10 melanoma cell lines (Po0.001). However, among the metastatic cell lines, we found some exceptions in which PEDF is expressed at significant levels, such as WM164 (Figure 2 ).
To further link decreased PEDF expression and melanoma aggressiveness we characterized molecular (E-cadherin (Li et al., 2001b) , N-cadherin (Li et al., 2001a) and microphthalmia-associated transcription factor (MITF) (Carreira et al., 2006) ) and functional (migration and invasion) markers of melanoma progression (Figures 2e-g ). Among the VGP and metastatic cell lines tested, PEDF was expressed only in WM3248 and WM164 cell lines, which retained the expression of either E-cadherin or MITF, resulting in a lower migratory and invasive capability. However, this correlation was not observed in the two RGP cell lines selected. WM35 had lost PEDF expression but expressed E-cadherin and MITF and showed no migratory or invasive capability. Conversely, SBcl2 expressed high levels of PEDF despite its high migratory and invasive potential, which was consistent with the loss of MITF and E-cadherin.
Considering the inherent difficulty in classifying melanoma, and the variability in PEDF expression in our limited series of cell lines, we aimed to expand our analysis to larger melanoma sets. We used a highthroughput analysis of the data from microarray studies available at Gene Expression Omnibus (GEO) database, which includes large series of human melanoma cell lines. We first analyzed whether PEDF expression was significantly altered between melanocyte and melanoma. We compared the normalized expression of PEDF averaged between the 28 independent primary melanocyte cultures versus expression in each melanoma data set (described in Supplementary Methods). Table 1a shows that there is a consistent and statistically significant downregulation of PEDF in the four melanoma cell line collections.
The attempts to classify melanoma according to molecular profiling have introduced a number of relevant concepts. The study by Hoek et al. (2006) identified molecular signatures differentiating weakly versus strongly invasive cohorts. We applied this classification to the four melanoma cell line series above, and we questioned whether PEDF was differentially expressed in the two cohorts. Figure 3 shows that PEDF is expressed at lower levels in the strongly invasive cohort in all series; this decrease was statistically significant in Mannheim and Philadelphia series (Table 1b) .
Despite the general trend toward PEDF loss during melanoma progression, we found some metastatic melanoma cell lines that retained high PEDF levels. We then hypothesized that (i) PEDF expression is reprogramed during the metastatic process and (ii) high PEDF expression is typical of the poorly invasive subpopulation within a metastatic lesion. To verify this hypothesis, we used paired cell lines representing the extreme phenotypes (highly and poorly aggressive) derived from an abdominal wall metastasis of a cutaneous human melanoma (Seftor et al., 2005) . Figure 4a shows morphological differences between the two cell lines, spindle-shaped poorly aggressive C81-61 and epithelioid highly aggressive C8161. Both C8161 and C81-61 expressed N-cadherin but have lost E-cadherin expression ( Figure 4b) ; however their aggressive traits differed significantly. C81-61 was less migratory (Figure 4c left) and invasive (Figure 4c right) , and grew poorly in soft agar (Figure 4d ). Accordingly, MITF expression was higher in the poorly aggressive C81-61 than in highly aggressive C8161 (Figure 4e ). Analysis of PEDF expression showed a striking difference between the two cell lines: poorly aggressive C81-61 expressed PEDF at levels comparable to those in melanocytes, whereas PEDF was undetectable in highly aggressive C8161, as was shown by western blot (Figure 4f (Figure 4f right) . Similarly, PEDF mRNA was high in C81-61 but undetectable in C8161 (Figure 4g ).
Heterogeneity of PEDF expression within a metastatic lesion was confirmed by immunohistochemistry in biopsies of lymph node and dermal metastasis. PEDF expression was highly positive in one out of five cases for PEDF silencing augments migratory capability, metastatic potential and vasculogenic mimicry of poorly aggressive melanoma cell lines To establish a causal connection between PEDF expression and melanoma aggressiveness and invasiveness, we explored the functional consequences of PEDF silencing in melanoma cell lines. We knocked down PEDF in poorly aggressive SBcl2 and WM164 melanoma cell lines using shRNA mir to PEDF (shPEDF) delivered by lentiviral transduction (Figure 5a ). Non-silencing (NS) shRNA mir was used as control. PEDF silencing was quantified by western blot ( Figure significantly increased by PEDF silencing (Figure 5f ). To evaluate whether the increase in migratory ability translated into augmented metastatic potential, we tested the capacity of SBcl2-NS versus SBcl2-shPEDF to form metastatic colonies in vivo. Interestingly, lungs of SBcl2-shPEDF-injected mice showed a higher number of microscopic GFP-positive tumor colonies compared with the lungs from SBcl2-NS-injected mice ( Figure 5g , upper panels). Histological examination confirmed the presence of larger metastases in SBcl2-shPEDF colonized lungs ( Figure 5g , lower panels). Quantitative analysis showed a significant increase in the number of colonies because of PEDF silencing (Figure 5g , right). We also examined the effect of PEDF interference in the poorly aggressive melanoma cell line C81-61. Despite effective PEDF silencing (Figure 6a ), there was no significant increase in migration (data not shown). As mentioned earlier, melanoma cells possess extreme plasticity and can be reprogramed to form Normalized PEDF signal intensity Johansson   0   10   20   30   40   50   60   70   A02  A04  A11  A15  D25  D28  D35  MM200  MM370  MM466  MM473  MM485  MM540  MM576  MM603  MM649  AF6  COLOF  D01  D08  D14  D22  D24  D29  D36  D38  HT144  MM127  MM229  MM455  MM595  MM608 vessel-like structures, a phenomenon termed vasculogenic mimicry (VM) (Hendrix et al., 2003) . Highly aggressive C8161 cells form vasculogenic networks, unlike the poorly aggressive C81-61 that adhere poorly to collagen matrix and fail to form cord-like structures (Seftor et al., 2005) . Interestingly, PEDF knockdown enabled C81-61 cells to spread out and form circular vasculogenic structures in 3D collagen matrix, indicative of VM, whereas NS shRNA mir had no effect (Figure 6b ). C81-61-shPEDF cells were not able to form colonies in the lungs 3 weeks after tail vein injection (Figure 6c) . Interestingly, PEDF knockdown provided signals that allowed the melanoma cells to form branching, vessellike structures and large lacunae containing red blood cells (Figure 6c top) . Immunostaining for GFP confirmed that these structures were formed by melanoma cells (Figure 6c bottom) . However, PEDF knockdown significantly increased the ability of poorly aggressive C81-61 cells implanted subcutaneously to form spontaneous metastasis to the lung after 9 weeks (Supplementary Figure 2a) .
We also over-expressed PEDF in the highly aggressive and invasive counterpart of C81-61 melanoma cell line, C8161. Efficient PEDF lentiviral transduction of C8161 cells was confirmed by GFP expression (Figure 6d , left) and analysis of PEDF expression by ELISA of CM (Figure 6d , middle) and quantitative RT-PCR (Figure 6d, right) . In agreement with our previous observations (Garcia et al., 2004) , PEDF over-expression reduced the number of surface lung metastases in a lung colonization assay (Figure 6e ) and the ability to form spontaneous metastases from a subcutaneous primary tumor (Supplementary Figure 2b) . Moreover, it reduced the formation of circular cords in 3D collagen matrix in vitro (Figure 6f ), as well as the presence of blood-filled lacunae in vivo (Figure 6e, lower panels) , indicative of VM, typical of C8161 cells (Hendrix et al., 2003; van der Schaft et al., 2004) .
PEDF silencing augments migration, invasion and proliferation of melanocytes As PEDF is highly expressed in melanocytes, we explored whether PEDF could have a direct functional role in these cells regulating their ability to migrate, invade and proliferate. PEDF knockdown in melanocytes (Figures 7a-c ) increased migration and invasion toward a variety of inducers (Figures 7d and e) . Furthermore, the proliferation of melanocytes was moderately increased by PEDF knockdown (Figure 7f) .
PEDF silencing did not alter the levels of E-cadherin protein and mRNA (Supplementary Figure 3) . Although we found a reduction in MITF mRNA expression on PEDF knockdown ( Supplementary Figure 4) , this result was not reproduced in a statistically significant number of experiments; MITF levels were reduced in three out of nine independent experiments using primary cultures from different donors. A reduction in MITF mRNA after PEDF silencing was also seen in the poorly aggressive melanoma cell lines WM164, C81-61 and M010817, but did not reproduce in a significant number of experiments (Supplementary Figure 4) . Thus, it is unlikely that the functional effects of PEDF silencing in melanocytes were mediated by E-Cadherin or MITF.
Discussion
Our understanding of melanoma biology remains incomplete despite several decades of intense research (Gray Schopfer et al., 2007) . The role of epigenetic factors and Abbreviation: PEDF, pigment epithelium-derived factor. Note: Although 'Melanocyte' refers to the same collection of cultures in each case, the normalized expression measurement is affected by the melanoma cell line dataset with which it is normalized and therefore the average value for PEDF should not be expected to remain static.
tumor microenvironment as major driving forces in melanoma progression has been presented with increasing molecular detail in recent years (Hendrix et al., 2007) .
Here, we describe the regulation of PEDF, a multifunctional endogenous factor, during melanoma progression and its functional consequences. We have demonstrated earlier that PEDF over-expression has multiple biological effects that overall profoundly affect melanoma aggressiveness by abrogating migration, driving apoptosis in melanoma cells under stress conditions, and acting as a potent anti-angiogenic factor (Garcia et al., 2004) . These results were extrapolated to other tumor types by a number of subsequent studies, which strongly support the potential use of PEDF for cancer therapy. Here, we show that PEDF is produced at high levels by melanocytes in the skin. Originally PEDF was found at high levels in retinal pigment epithelial cells. Although both melanocytes and retinal pigment epithelial cells are pigment producing cells, they have different developmental origin and display distinct biological roles (Sato and Yamamoto, 2001) . PEDF has multiple functions, some of which are cell type specific, such as neurotrophic or neuroprotective properties, whereas others, including inhibition of proliferation, migration and induction of apoptosis, affect multiple cell types. The functional role of PEDF in pigment producing cells has not yet been addressed. Here, we show that knockdown of endogenous PEDF expression in melanocytes translates into increased migration, invasion and proliferation, suggesting a role for PEDF in melanocyte homeostasis. Further studies comparing PEDF expression in highly migratory neural crest precursors and in less migratory mature melanocytes in the epidermis, may provide valuable clues into the functional roles of PEDF in pigment producing cells.
PEDF is expressed at high levels in a significant percentage of melanoma lesions although the high variance found in its expression levels suggested that regulation of PEDF expression may underlie some aspects of melanoma progression. In our study, we used several approaches to establish a robust conclusion concerning PEDF loss during melanoma progression and its functional consequences.
We used the information from high-throughput microarray analysis available at GEO databases to analyze possible correlation of PEDF expression with molecular staging of melanoma. The comparison of normalized data from several independent studies showed that PEDF was significantly downregulated in melanoma cell lines compared with melanocyte cultures. This analysis also showed that PEDF expression was highly variable between melanoma cell lines. We therefore looked for a sub-classification that would reflect the principle underlying PEDF variation. Gene expression profiling has been used to define molecular taxonomy of human melanoma, which reflects certain functional criteria. Hoek et al. (2008) used the combination of gene expression profiling and functional tests to introduce a hypothesis in which melanoma cells are classified into weakly or strongly invasive, and bidirectional switch between these phenotypes drives progression. We found that high PEDF expression was characteristic of weakly invasive melanoma cell lines.
On the other hand, our study suggested that PEDF expression in melanoma cells is subject to plasticity. This was supported by our results in paired cell lines established from a single lesion, in which PEDF expression was restricted to the poorly aggressive counterpart. Therefore, a single melanoma lesion may contain PEDF-positive and -negative cells and reprograming of PEDF expression may reflect the reversible transitions between proliferative and invasive states required during the metastatic process. In keeping with this hypothesis, melanoma biopsies from the lymph node and dermal metastases showed heterogeneous expression of PEDF and in one out of five cases PEDF was expressed at high levels.
To assess the functional consequences of PEDF loss during malignant progression of human melanoma we used a direct molecular analysis based on RNA interference. Silencing of endogenous PEDF expression in poorly aggressive human melanoma cell lines increased their migratory and invasive ability and translated into a higher metastatic potential in vivo. Additional traits modulated by PEDF, such as the ability to proliferate and induce angiogenesis (Garcia et al., 2004) , could also contribute to the observed increased metastatic potential.
Interestingly, PEDF silencing increased VM, one of the phenomena reflecting melanoma plasticity during the invasion-metastasis cascade (Hendrix et al., 2003) . The ability of PEDF to curtail VM is especially noteworthy, as it was unaffected by established angiogenesis inhibitors such as anginex, TNP-470 and endostatin (van der Schaft et al., 2004) .
Possible regulatory mechanisms underlying the changes in PEDF expression during transformation and malignant progression of melanoma are presently unknown, although there are several likely candidates. Regulators of neovascularization, such as PEDF, are controlled through the gain of oncogenes and the loss of tumor suppressor genes (Bouck, 1990) . PEDF is a direct target of p53 family members in colorectal cancer cell lines (Sasaki et al., 2005) . Decreased PEDF expression correlates with the expression of DEX2p73, or with K-ras oncogenic mutations in human colorectal cancer (Diaz et al., 2008) . The role of p73 in melanoma genesis is poorly defined. A recent study shows that TA-p73 abrogates anchorage-independent growth through regulation of KCNK1, which is frequently lost in melanoma (Beitzinger et al., 2008) . N-ras oncogenic mutations are found in 20% of human melanomas and provide a proliferative advantage early in transformation (Chin, 2003) . Analysis of GEO databases for possible correlation between PEDF expression and B-RAF or N-ras mutations in melanoma yielded no significant correlation. Regulatory signals from the melanoma microenvironment may also influence PEDF expression. We found a nine-fold decrease in PEDF expression in primary melanocytes grown on collagen matrix preconditioned by a highly aggressive melanoma cell line, as compared with melanocytes grown on collagen without preconditioning (data not shown) (Seftor et al., 2005) . Additionally, hypoxia is a relevant trigger of the angiogenic switch and other epigenetic changes contributing to metastasis. PEDF is downregulated by hypoxia in retinoblastoma (Dawson et al., 1999) and retinal pigment epithelial cells (Notari et al., 2005) . We also found that PEDF is downregulated by hypoxia in melanocytes and melanoma cell lines (data not shown).
In summary, our study shows that PEDF is expressed at high levels in the melanocyte, in which it contributes to restrict the growth, migration and invasion of melanocytes. PEDF expression is modulated in a complex fashion during malignant progression of human melanoma, in which it is likely reprogramed to meet the current demand for proliferation, migration, invasion or angiogenesis.
Materials and methods

Cell culture
See Supplementary Methods for a detailed description of the cell lines used.
Immunoblotting Whole-cell lysates or CM were prepared and analyzed as described (Fernandez-Garcia et al., 2005) , and 15 mg whole-cell protein extracts or 1.5 mg CM were loaded per lane. Specific primary antibodies and dilutions are listed in Supplementary Table 1. ELISA Secreted PEDF protein levels in CM were quantified using ELISAquant PEDF Sandwich ELISA Antigen Detection kit following the manufacturer's instructions (Bioproducts MD LLC, Middletown, MD, USA).
Immunofluorescence and immunohistochemistry
Immunofluorescence and immunohistochemistry methods are included in Supplementary Methods.
RNA extraction and quantitative RT-PCR
Total RNA was isolated using TRIzol (Molecular Research Center Inc., Cincinnati, OH, USA) and was retrotranscribed to cDNA using high-capacity cDNA Archive kit (Applied Biosystems, Foster City, CA, USA). See Supplementary Methods for the probes and oligonucleotides used. The quantitative PCR reaction was performed in an ABI Prism 7900 HT thermal cycler (Applied Biosystems) following the manufacturer's protocols. Relative mRNA levels were calculated using the comparative C T method as recommended by Applied Biosystems.
Microarray data analysis
Previously published DNA microarray data sets comprising series of primary melanocytes or melanoma cell lines were downloaded from public database websites and analyzed as indicated in Supplementary Methods.
RNA interference
PEDF knockdown was achieved using the lentiviral vector pGIPz containing the shRNA mir sequence VL2HS_221662 from Open Biosystems (Huntsville, AL, USA). NS shRNA mir sequence cloned into pGIPz vector and with no homology to known mammalian genes was used as control (Open Biosystems).
PEDF over-expression
For PEDF over-expression, we generated lentiviral constructs in prrl.CMV.EGFP.wpre.SIN vector encoding the full-length human PEDF cDNA as indicated in Supplementary Methods. over-expressing cell lines were enriched for GFP expression by fluorescence-activated cell sorting. For PEDF-knockdown cell lines, cells were selected with 0.25-1 mg/ml puromycin (Calbiochem-Novabiochem Corp., La Jolla, CA, USA) for 4 days. gelatin-coated filters as described (Garcia et al., 2004) . To evaluate cell invasion, the filters were coated with 12 mg Matrigel (primary melanocytes) or growth factor reduced Matrigel (melanoma cell lines) (BD Biosciences, Bedford, MA, USA) diluted in 100 ml serum-free medium, and air dried overnight. As chemoattractants, 10% fetal bovine serum; 30 ng/ ml bFGF (Peprotech, London, UK); 100 ng/ml IL8 (Preprotech); or 10-25 mg/ml CM from NIH-3T3 cells were used. After incubation for the indicated time periods, non-migrated cells were wiped off using a cotton swab, and the filters were stained with Diff Quik (Dade Behring, Newark, DE, USA). Migrated cells were counted at 10 areas of maximum migration under a light microscope at Â 40 magnification. Average±standard deviation (s.d.) values shown are representative of at least three independent experiments.
Migration and invasion assays
Proliferation assays
Melanocyte S-phase entry was analyzed by the incorporation of 5-ethynyl-2-deoxyuridine (EdU) using the Click-iT EdU Imaging kit (Invitrogen, Paisley, UK) as indicated by the manufacturer. EdU-positive cells were counted in six different fields using a TCS SP5 DMI6000 spectral confocal microscope (Leica Microsystems, Heidelberg, Germany). Melanocyte viability was also measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma), following the manufacturer's instructions. Results using EdU and MTT were confirmed in two independent primary cultures, and a representative experiment is shown.
In vitro VM assay Tissue culture plates were coated with collagen I (BD Discovery Labware, Bedford, MA, USA), soaked in ethanol and rinsed in PBS; 5 Â 10 5 cells were seeded on the matrix in 24-well plates in regular growth media and left to grow for up to 8 days. Images were taken on day 6.
Colony formation assay A total of 2.5 Â 10 4 cells were resuspended in 0.35% Noble agar (BD Biosciences) in RPMI with 10% fetal bovine serum and seeded on 0.5% Noble agar in the same medium in 6-well plates. Phase-contrast micrographs were taken after 11 days of culture using a magnifying glass at Â 0.7.
Lung colonization assay NOD/SCID mice (Harlan Laboratories, Madison, WI, USA; 5 mice per group) were injected through the tail vein with melanoma cells suspended in 100 ml PBS (1 Â 10 6 cells for SBcl2-NS, SBcl2-shPEDF, C81-61-NS and C81-61-shPEDF cell lines; 1 Â 10 5 cells for C8161-GFP or C8161-PEDF cell lines). At the end point (92 days for SBcl2-NS-and SBcl2-shPEDF-injected mice; 21 days for C81-61-NS-and C81-61-shPEDF-injected mice; and 28 days for C8161-GFP-and C8161-PEDF-injected mice) the mice were killed, the lungs removed and photographed using Olympus OV100 Small Animal Imaging System (Olympus Corp., Tokyo, Japan), and surface metastases were counted manually. The lungs were formalin fixed, paraffin embedded and sectioned for further analysis. Hematoxylin/eosin staining was performed at Northwestern University Pathology Core.
Spontaneous metastasis assay
Melanoma cells were injected subcutaneously into the right flank of nude mice (Harlan Laboratories) (1 Â 10 6 cells/flank for C8161-derived cell lines and 2 Â 10 6 cells/flank for C81-61-derived cell lines; 10 mice/cell line) and the tumors were allowed to grow for 4 weeks (C8161-derived cell lines) or 9 weeks (C81-61-derived cell lines). The animals were killed, the lungs and livers excised, rinsed in PBS and fluorescence images were taken using Olympus OV100 Small Animal Imaging System (Olympus Corp.). The number of surface lesions was determined on digital images using MetaMorph software package (MDS Analytical Technologies, Sunnyvale, CA, USA).
Statistical analysis
All statistical analyses were performed using GraphPad Instat (GraphPad Software, San Diego, CA, USA). P-values p 0.05 were considered as significant. and M20-NS and M20-shPEDF (right) melanocytes toward 30 ng/ml bFGF, 100 ng/ml IL8 or 15 mg/ml CM from NIH-3T3 cells for 22 h. Statistical significance was determined by ANOVA using Tukey-Kramer post-test (**Po0.01; ***Po0.001). (e) Invasion assay of M20-NS and M20-shPEDF melanocytes toward 25 mg/ml CM from NIH-3T3 cells for 24 h. Statistical significance was determined by Student's t-test (***Po0.001). (f) Proliferation assays. Proliferation curves of M20-NS (solid line) and M20-shPEDF (dashed line) melanocytes growing in the presence of serum. MTT assay was performed at the indicated time points (left panel). Right panel shows 5-ethynyl-2-deoxyuridine (EdU) incorporation of M20-NS and M20-shPEDF melanocytes. Cells were serum-starved for 24 h and then were allowed to grow in the presence of 20 mM EdU in serum-free medium or 10% FBS-containing medium for another 24 h. Bars represent average ± s.d. Statistical significance was determined by Student's t-test (**Po0.01; ***Po0.01).
